A phase III, multicenter, open-label, randomised study to evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (B-Pd) versus pomalidomide plus bortezomib and dexamethasone (PVd) in participants with relapsed/refractory multiple myeloma [207499] [DREAMM 8]

  • Kenealy, Melita (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date27/01/21 → 31/12/23

Keywords

  • Malignant Haematology
  • multiple myeloma
  • Clinical trial

Clinical Trial Phase

  • Phase III (a & b)